Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluating patient-derived colorectal cancer xenografts as preclinical models by comparison with patient clinical data.
Nunes M, Vrignaud P, Vacher S, Richon S, Lièvre A, Cacheux W, Weiswald LB, Massonnet G, Chateau-Joubert S, Nicolas A, Dib C, Zhang W, Watters J, Bergstrom D, Roman-Roman S, Bièche I, Dangles-Marie V. Nunes M, et al. Among authors: vrignaud p. Cancer Res. 2015 Apr 15;75(8):1560-6. doi: 10.1158/0008-5472.CAN-14-1590. Epub 2015 Feb 24. Cancer Res. 2015. PMID: 25712343
Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer.
Julien S, Merino-Trigo A, Lacroix L, Pocard M, Goéré D, Mariani P, Landron S, Bigot L, Nemati F, Dartigues P, Weiswald LB, Lantuas D, Morgand L, Pham E, Gonin P, Dangles-Marie V, Job B, Dessen P, Bruno A, Pierré A, De Thé H, Soliman H, Nunes M, Lardier G, Calvet L, Demers B, Prévost G, Vrignaud P, Roman-Roman S, Duchamp O, Berthet C. Julien S, et al. Among authors: vrignaud p. Clin Cancer Res. 2012 Oct 1;18(19):5314-28. doi: 10.1158/1078-0432.CCR-12-0372. Epub 2012 Jul 23. Clin Cancer Res. 2012. PMID: 22825584
[Preclinical models in oncology].
Vrignaud P. Vrignaud P. Bull Cancer. 2011 Nov;98(11):1355-61. doi: 10.1684/bdc.2011.1473. Bull Cancer. 2011. PMID: 22023796 French.
Mechanisms of resistance to cabazitaxel.
Duran GE, Wang YC, Francisco EB, Rose JC, Martinez FJ, Coller J, Brassard D, Vrignaud P, Sikic BI. Duran GE, et al. Among authors: vrignaud p. Mol Cancer Ther. 2015 Jan;14(1):193-201. doi: 10.1158/1535-7163.MCT-14-0155. Epub 2014 Nov 21. Mol Cancer Ther. 2015. PMID: 25416788 Free PMC article.
Preclinical profile of cabazitaxel.
Vrignaud P, Semiond D, Benning V, Beys E, Bouchard H, Gupta S. Vrignaud P, et al. Drug Des Devel Ther. 2014 Oct 13;8:1851-67. doi: 10.2147/DDDT.S64940. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25378905 Free PMC article. Review.
Docetaxel chronopharmacology in mice.
Tampellini M, Filipski E, Liu XH, Lemaigre G, Li XM, Vrignaud P, François E, Bissery MC, Lévi F. Tampellini M, et al. Among authors: vrignaud p. Cancer Res. 1998 Sep 1;58(17):3896-904. Cancer Res. 1998. PMID: 9731500
55 results